Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia

Author(s): Gerard E. Dwyer*, Kenneth Hugdahl, Karsten Specht, Renate Grüner

Journal Name: Current Topics in Medicinal Chemistry

Volume 18 , Issue 21 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Magnetic Resonance Spectroscopy (MRS) has become a valuable tool for investigating the biochemical bases of both normal processes in the healthy brain and elucidating the pathophysiology of neuropsychiatric disorders. As a rapidly advancing field, new developments in pulse sequence design have seen new possibilities arise in terms of what can be done with in vivo spectroscopy. While the applications of MRS are numerous, this review has been confined to the use of single voxel spectroscopy in the assessment of five key metabolites and their roles in schizophrenia: N-acetylaspartate (NAA), glutamate (Glu) and glutamine (Gln), γ-aminobutyric acid (GABA) and glutathione (GSH). This article will briefly cover the roles they play in schizophrenia, review current methods being used in their assessment and highlight new approaches that may potentially overcome some of the limitations current methods pose.

Keywords: Magnetic Resonance Spectroscopy, MRS, Schizophrenia, Glutamate, Glutamine, GABA, NAA, GSH.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [1908 - 1924]
Pages: 17
DOI: 10.2174/1568026619666181130103559

Article Metrics

PDF: 60
HTML: 10